●A controlled human infection model could greatly enhance our ability to produce new tuberculosis vaccines. How could that be done safely and still be informative?
●The New England Journal of Medicine publishes many studies that immediately affect medicalpractice and health policy. How does the decision-making process work and how does that affect you as an author?
●This seminar was jointly held by UTOPIA and IJURC.
* The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA)
* IMSUT International Joint Usage/Research Center (IJURC)
Combatting tuberculosis and publishing in medical journals
Joint Research Seminar
Event Information
| Date and Time | 2024/07/12 (Friday) 16:00~ 17:30 |
|---|---|
| Venue | Auditorium |
| Speaker | ERIC J. RUBIN, MD, PHD |
| Affiliation/Position | Editor-in-Chief, The New England Journal of Medicine, NEJM Group |
| Country | U.S.A. |
| Title | Combatting tuberculosis and publishing in medical journals |
| Language | English |
| Organizer | Professor Yoshihiro Kawaoka |